ID   PHKG2_HUMAN             Reviewed;         406 AA.
AC   P15735; A8K0C7; B4DEB7; E9PEU3; P11800;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1990, sequence version 1.
DT   10-MAY-2017, entry version 193.
DE   RecName: Full=Phosphorylase b kinase gamma catalytic chain, liver/testis isoform;
DE            Short=PHK-gamma-LT;
DE            Short=PHK-gamma-T;
DE            EC=2.7.11.19;
DE   AltName: Full=PSK-C3;
DE   AltName: Full=Phosphorylase kinase subunit gamma-2;
GN   Name=PHKG2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=2915644; DOI=10.1210/mend-3-1-110;
RA   Hanks S.K.;
RT   "Messenger ribonucleic acid encoding an apparent isoform of
RT   phosphorylase kinase catalytic subunit is abundant in the adult
RT   testis.";
RL   Mol. Endocrinol. 3:110-116(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=9384616; DOI=10.1093/hmg/7.1.149;
RA   Burwinkel B., Shiomi S., Al Zaben A., Kilimann M.W.;
RT   "Liver glycogenosis due to phosphorylase kinase deficiency: PHKG2 gene
RT   structure and mutations associated with cirrhosis.";
RL   Hum. Mol. Genet. 7:149-154(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X.,
RA   Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A.,
RA   Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J.,
RA   Buckingham J.M., Callen D.F., Campbell C.S., Campbell M.L.,
RA   Campbell E.W., Caoile C., Challacombe J.F., Chasteen L.A.,
RA   Chertkov O., Chi H.C., Christensen M., Clark L.M., Cohn J.D.,
RA   Denys M., Detter J.C., Dickson M., Dimitrijevic-Bussod M., Escobar J.,
RA   Fawcett J.J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., Grigoriev I.,
RA   Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., Huang W.,
RA   Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., Kobayashi A.,
RA   Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., Lowry S.,
RA   Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L.,
RA   Rash S., Retterer J., Ricke D.O., Robinson D.L., Rodriguez A.,
RA   Salamov A., Saunders E.H., Scott D., Shough T., Stallings R.L.,
RA   Stalvey M., Sutherland R.D., Tapia R., Tesmer J.G., Thayer N.,
RA   Thompson L.S., Tice H., Torney D.C., Tran-Gyamfi M., Tsai M.,
RA   Ulanovsky L.E., Ustaszewska A., Vo N., White P.S., Williams A.L.,
RA   Wills P.L., Wu J.-R., Wu K., Yang J., DeJong P., Bruce D.,
RA   Doggett N.A., Deaven L., Schmutz J., Grimwood J., Richardson P.,
RA   Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., Myers R.M.,
RA   Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 129-273.
RX   PubMed=2948189; DOI=10.1073/pnas.84.2.388;
RA   Hanks S.K.;
RT   "Homology probing: identification of cDNA clones encoding members of
RT   the protein-serine kinase family.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:388-392(1987).
RN   [7]
RP   INVOLVEMENT IN GSD9C.
RX   PubMed=9245685; DOI=10.1006/bbrc.1997.7006;
RA   van Beurden E.A., de Graaf M., Wendel U., Gitzelmann R., Berger R.,
RA   van den Berg I.E.;
RT   "Autosomal recessive liver phosphorylase kinase deficiency caused by a
RT   novel splice-site mutation in the gene encoding the liver gamma
RT   subunit (PHKG2).";
RL   Biochem. Biophys. Res. Commun. 236:544-548(1997).
RN   [8]
RP   FUNCTION, AND STRUCTURE.
RX   PubMed=10487978; DOI=10.2741/Brushia;
RA   Brushia R.J., Walsh D.A.;
RT   "Phosphorylase kinase: the complexity of its regulation is reflected
RT   in the complexity of its structure.";
RL   Front. Biosci. 4:D618-D641(1999).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-345, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 6-293 IN COMPLEX WITH
RP   INHIBITOR.
RG   Structural genomics consortium (SGC);
RT   "Structure of human phosphorylase kinase, gamma 2.";
RL   Submitted (FEB-2011) to the PDB data bank.
RN   [13]
RP   VARIANTS GSD9C GLU-106 AND GLU-189.
RX   PubMed=8896567; DOI=10.1038/ng1196-337;
RA   Maichele A.J., Burwinkel B., Maire I., Sovik O., Kilimann M.W.;
RT   "Mutations in the testis/liver isoform of the phosphorylase kinase
RT   gamma subunit (PHKG2) cause autosomal liver glycogenosis in the gsd
RT   rat and in humans.";
RL   Nat. Genet. 14:337-340(1996).
RN   [14]
RP   VARIANTS GSD9C LYS-157 AND ASN-215.
RX   PubMed=12930917; DOI=10.1203/01.PDR.0000088069.09275.10;
RA   Burwinkel B., Rootwelt T., Kvittingen E.A., Chakraborty P.K.,
RA   Kilimann M.W.;
RT   "Severe phenotype of phosphorylase kinase-deficient liver glycogenosis
RT   with mutations in the PHKG2 gene.";
RL   Pediatr. Res. 54:834-839(2003).
RN   [15]
RP   VARIANT [LARGE SCALE ANALYSIS] THR-317.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Catalytic subunit of the phosphorylase b kinase (PHK),
CC       which mediates the neural and hormonal regulation of glycogen
CC       breakdown (glycogenolysis) by phosphorylating and thereby
CC       activating glycogen phosphorylase. May regulate glycogeneolysis in
CC       the testis. In vitro, phosphorylates PYGM (By similarity).
CC       {ECO:0000250, ECO:0000269|PubMed:10487978}.
CC   -!- CATALYTIC ACTIVITY: 2 ATP + phosphorylase b = 2 ADP +
CC       phosphorylase a.
CC   -!- SUBUNIT: Hexadecamer of 4 heterotetramers, each composed of alpha,
CC       beta, gamma, and delta subunits. Alpha (PHKA1 or PHKA2) and beta
CC       (PHKB) are regulatory subunits, gamma (PHKG1 or PHKG2) is the
CC       catalytic subunit, and delta is calmodulin. {ECO:0000269|Ref.12}.
CC   -!- INTERACTION:
CC       P46019:PHKA2; NbExp=4; IntAct=EBI-1383819, EBI-1642846;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P15735-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P15735-2; Sequence=VSP_041858, VSP_041859;
CC   -!- DISEASE: Glycogen storage disease 9C (GSD9C) [MIM:613027]: A
CC       metabolic disorder manifesting in infancy with hepatomegaly,
CC       growth retardation, hypotonia, liver dysfunction, and elevated
CC       plasma aminotransferases and lipids. These symptoms improve with
CC       age in most cases; however, some patients may develop hepatic
CC       fibrosis or cirrhosis. {ECO:0000269|PubMed:12930917,
CC       ECO:0000269|PubMed:8896567, ECO:0000269|PubMed:9245685}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK
CC       Ser/Thr protein kinase family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M31606; AAA36442.1; -; mRNA.
DR   EMBL; Y11950; CAA72694.1; -; Genomic_DNA.
DR   EMBL; Y11951; CAA72694.1; JOINED; Genomic_DNA.
DR   EMBL; AK289492; BAF82181.1; -; mRNA.
DR   EMBL; AK293551; BAG57028.1; -; mRNA.
DR   EMBL; AC106886; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC002541; AAH02541.1; -; mRNA.
DR   EMBL; M14503; AAA36518.1; -; mRNA.
DR   CCDS; CCDS10690.1; -. [P15735-1]
DR   CCDS; CCDS54002.1; -. [P15735-2]
DR   PIR; A40069; KIHUCT.
DR   RefSeq; NP_000285.1; NM_000294.2. [P15735-1]
DR   RefSeq; NP_001165903.1; NM_001172432.1. [P15735-2]
DR   UniGene; Hs.65735; -.
DR   PDB; 2Y7J; X-ray; 2.50 A; A/B/C/D=6-293.
DR   PDBsum; 2Y7J; -.
DR   ProteinModelPortal; P15735; -.
DR   SMR; P15735; -.
DR   BioGrid; 111279; 53.
DR   IntAct; P15735; 31.
DR   STRING; 9606.ENSP00000455607; -.
DR   BindingDB; P15735; -.
DR   ChEMBL; CHEMBL2349; -.
DR   GuidetoPHARMACOLOGY; 2147; -.
DR   iPTMnet; P15735; -.
DR   PhosphoSitePlus; P15735; -.
DR   BioMuta; PHKG2; -.
DR   DMDM; 125536; -.
DR   EPD; P15735; -.
DR   MaxQB; P15735; -.
DR   PaxDb; P15735; -.
DR   PeptideAtlas; P15735; -.
DR   PRIDE; P15735; -.
DR   DNASU; 5261; -.
DR   Ensembl; ENST00000424889; ENSP00000388571; ENSG00000156873. [P15735-2]
DR   Ensembl; ENST00000563588; ENSP00000455607; ENSG00000156873. [P15735-1]
DR   GeneID; 5261; -.
DR   KEGG; hsa:5261; -.
DR   UCSC; uc021tgo.3; human. [P15735-1]
DR   CTD; 5261; -.
DR   DisGeNET; 5261; -.
DR   GeneCards; PHKG2; -.
DR   GeneReviews; PHKG2; -.
DR   HGNC; HGNC:8931; PHKG2.
DR   HPA; HPA065618; -.
DR   HPA; HPA068751; -.
DR   MalaCards; PHKG2; -.
DR   MIM; 172471; gene.
DR   MIM; 613027; phenotype.
DR   neXtProt; NX_P15735; -.
DR   OpenTargets; ENSG00000156873; -.
DR   Orphanet; 264580; Glycogen storage disease due to liver phosphorylase kinase deficiency.
DR   PharmGKB; PA33272; -.
DR   eggNOG; KOG0599; Eukaryota.
DR   eggNOG; ENOG410Y7VX; LUCA.
DR   GeneTree; ENSGT00840000129744; -.
DR   HOGENOM; HOG000233016; -.
DR   HOVERGEN; HBG106193; -.
DR   InParanoid; P15735; -.
DR   KO; K00871; -.
DR   PhylomeDB; P15735; -.
DR   TreeFam; TF320349; -.
DR   BioCyc; MetaCyc:HS08155-MONOMER; -.
DR   BRENDA; 2.7.11.19; 2681.
DR   Reactome; R-HSA-70221; Glycogen breakdown (glycogenolysis).
DR   SignaLink; P15735; -.
DR   ChiTaRS; PHKG2; human.
DR   GeneWiki; PHKG2; -.
DR   GenomeRNAi; 5261; -.
DR   PRO; PR:P15735; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000156873; -.
DR   CleanEx; HS_PHKG2; -.
DR   ExpressionAtlas; P15735; baseline and differential.
DR   Genevisible; P15735; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005964; C:phosphorylase kinase complex; TAS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005516; F:calmodulin binding; IEA:UniProtKB-KW.
DR   GO; GO:0019899; F:enzyme binding; IEA:Ensembl.
DR   GO; GO:0004689; F:phosphorylase kinase activity; TAS:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; TAS:UniProtKB.
DR   GO; GO:0050321; F:tau-protein kinase activity; TAS:UniProtKB.
DR   GO; GO:0006091; P:generation of precursor metabolites and energy; TAS:ProtInc.
DR   GO; GO:0005978; P:glycogen biosynthetic process; IEA:InterPro.
DR   GO; GO:0005980; P:glycogen catabolic process; TAS:Reactome.
DR   GO; GO:0005977; P:glycogen metabolic process; TAS:ProtInc.
DR   GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IBA:GO_Central.
DR   GO; GO:0018107; P:peptidyl-threonine phosphorylation; IBA:GO_Central.
DR   GO; GO:0045819; P:positive regulation of glycogen catabolic process; TAS:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; TAS:ProtInc.
DR   InterPro; IPR020636; Ca/CaM-dep_Ca-dep_prot_Kinase.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR002291; Phosph_kin_gamma.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   PANTHER; PTHR24347; PTHR24347; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   PRINTS; PR01049; PHOSPHBKNASE.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Calmodulin-binding;
KW   Carbohydrate metabolism; Complete proteome; Disease mutation;
KW   Glycogen metabolism; Glycogen storage disease; Kinase;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    406       Phosphorylase b kinase gamma catalytic
FT                                chain, liver/testis isoform.
FT                                /FTId=PRO_0000086512.
FT   DOMAIN       24    291       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND      30     38       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   REGION      306    330       Calmodulin-binding (domain-N).
FT                                {ECO:0000250}.
FT   REGION      346    370       Calmodulin-binding (domain-C).
FT                                {ECO:0000250}.
FT   ACT_SITE    153    153       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING      53     53       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES     345    345       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ     362    374       VKKGEQQNRAALF -> IRKQWIGKLMACV (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_041858.
FT   VAR_SEQ     375    406       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_041859.
FT   VARIANT     106    106       V -> E (in GSD9C; dbSNP:rs137853589).
FT                                {ECO:0000269|PubMed:8896567}.
FT                                /FTId=VAR_009517.
FT   VARIANT     157    157       E -> K (in GSD9C; dbSNP:rs752961445).
FT                                {ECO:0000269|PubMed:12930917}.
FT                                /FTId=VAR_020854.
FT   VARIANT     189    189       G -> E (in GSD9C; dbSNP:rs137853588).
FT                                {ECO:0000269|PubMed:8896567}.
FT                                /FTId=VAR_009518.
FT   VARIANT     215    215       D -> N (in GSD9C; dbSNP:rs767427889).
FT                                {ECO:0000269|PubMed:12930917}.
FT                                /FTId=VAR_020855.
FT   VARIANT     247    247       E -> G (in dbSNP:rs34006569).
FT                                /FTId=VAR_051658.
FT   VARIANT     317    317       A -> T (in dbSNP:rs759992249).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040996.
FT   CONFLICT    146    146       A -> P (in Ref. 6; AAA36518).
FT                                {ECO:0000305}.
FT   CONFLICT    176    176       C -> S (in Ref. 6; AAA36518).
FT                                {ECO:0000305}.
FT   CONFLICT    179    179       E -> D (in Ref. 6; AAA36518).
FT                                {ECO:0000305}.
FT   CONFLICT    212    214       KEV -> LVD (in Ref. 6; AAA36518).
FT                                {ECO:0000305}.
FT   CONFLICT    221    221       V -> E (in Ref. 6; AAA36518).
FT                                {ECO:0000305}.
FT   HELIX        13     23       {ECO:0000244|PDB:2Y7J}.
FT   STRAND       24     32       {ECO:0000244|PDB:2Y7J}.
FT   STRAND       34     43       {ECO:0000244|PDB:2Y7J}.
FT   TURN         44     46       {ECO:0000244|PDB:2Y7J}.
FT   STRAND       49     56       {ECO:0000244|PDB:2Y7J}.
FT   HELIX        64     84       {ECO:0000244|PDB:2Y7J}.
FT   STRAND       93    107       {ECO:0000244|PDB:2Y7J}.
FT   HELIX       115    122       {ECO:0000244|PDB:2Y7J}.
FT   HELIX       127    146       {ECO:0000244|PDB:2Y7J}.
FT   HELIX       156    158       {ECO:0000244|PDB:2Y7J}.
FT   STRAND      159    161       {ECO:0000244|PDB:2Y7J}.
FT   STRAND      167    169       {ECO:0000244|PDB:2Y7J}.
FT   HELIX       191    193       {ECO:0000244|PDB:2Y7J}.
FT   HELIX       196    201       {ECO:0000244|PDB:2Y7J}.
FT   HELIX       214    228       {ECO:0000244|PDB:2Y7J}.
FT   HELIX       238    247       {ECO:0000244|PDB:2Y7J}.
FT   HELIX       254    257       {ECO:0000244|PDB:2Y7J}.
FT   STRAND      258    260       {ECO:0000244|PDB:2Y7J}.
FT   HELIX       262    271       {ECO:0000244|PDB:2Y7J}.
FT   TURN        276    278       {ECO:0000244|PDB:2Y7J}.
FT   HELIX       282    287       {ECO:0000244|PDB:2Y7J}.
FT   HELIX       289    291       {ECO:0000244|PDB:2Y7J}.
SQ   SEQUENCE   406 AA;  46442 MW;  E991CFF2D3D70F60 CRC64;
     MTLDVGPEDE LPDWAAAKEF YQKYDPKDVI GRGVSSVVRR CVHRATGHEF AVKIMEVTAE
     RLSPEQLEEV REATRRETHI LRQVAGHPHI ITLIDSYESS SFMFLVFDLM RKGELFDYLT
     EKVALSEKET RSIMRSLLEA VSFLHANNIV HRDLKPENIL LDDNMQIRLS DFGFSCHLEP
     GEKLRELCGT PGYLAPEILK CSMDETHPGY GKEVDLWACG VILFTLLAGS PPFWHRRQIL
     MLRMIMEGQY QFSSPEWDDR SSTVKDLISR LLQVDPEARL TAEQALQHPF FERCEGSQPW
     NLTPRQRFRV AVWTVLAAGR VALSTHRVRP LTKNALLRDP YALRSVRHLI DNCAFRLYGH
     WVKKGEQQNR AALFQHRPPG PFPIMGPEEE GDSAAITEDE AVLVLG
//
